MDM2 Upregulation: A Novel Molecular Marker in Meningioma

被引：0
|
作者：
Behbahanian, Yalda [1 ]
Yong, William [1 ]
Vinters, Harry [1 ]
Khanlou, Negar [1 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1712
引用
收藏
页码：429A / 429A
页数：1
相关论文
共 50 条
  • [1] MDM2 Upregulation: A Novel Molecular Marker in Meningioma
    Behbahanian, Yalda
    Yong, William
    Vinters, Harry
    Khanlou, Negar
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 429A - 429A
  • [2] The molecular dynamics of MDM2
    Nicholson, Judith
    Hupp, Ted R.
    [J]. CELL CYCLE, 2010, 9 (10) : 1878 - 1881
  • [3] Targeting MDM2 for novel molecular therapy: Beyond oncology
    Wang, Wei
    Qin, Jiang-Jiang
    Rajaei, Mehrdad
    Li, Xin
    Yu, Xiaoyi
    Hunt, Courtney
    Zhang, Ruiwen
    [J]. MEDICINAL RESEARCH REVIEWS, 2020, 40 (03) : 856 - 880
  • [4] A rare case of atypical/anaplastic meningioma with MDM2 amplification
    Wylleman, Robbert
    Debiec-Rychter, Maria
    Sciot, Raf
    [J]. RARE TUMORS, 2018, 10
  • [5] Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction
    Inuzuka, Hiroyuki
    Fukushima, Hidefumi
    Shaik, Shavali
    Wei, Wenyi
    [J]. ONCOTARGET, 2010, 1 (07) : 685 - 690
  • [6] MDM2 — a novel target in glomerulonephritis
    Jessica K. Edwards
    [J]. Nature Reviews Nephrology, 2016, 12 (6) : 316 - 316
  • [7] Design and In Silico Study of the Novel Small Molecular MDM2 Inhibitors
    Gohil, Chiragkumar J.
    Noolvi, Malleshappa N.
    [J]. BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2021, 11 (01): : 8052 - 8064
  • [8] MDM2 is a useful diagnostic marker for nasopharyngeal carcinoma
    Taverna, Cecilia
    Agaimy, Abbas
    Franchi, Alessandro
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2022, 236
  • [9] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielson, TO
    Gilks, CB
    Huntsman, DG
    [J]. MODERN PATHOLOGY, 2005, 18 : 53A - 53A
  • [10] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielsen, TO
    Gilks, CB
    Huntsman, DG
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 53A - 53A
12345